Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
In Silico ADME/Tox Products Market 2006
In Silico predictive ADME/Tox screening is one of the hottest areas in drug discovery. It is widely perceived that the early screening of chemical entities can significantly reduce the expensive costs associated with late stage failures of drugs due to poor ADME/Tox properties. This market research report from Select Biosciences provides an up-to-date overview and analysis of technology, business, regulatory trends and key product profiles.
In this report Select Biosciences presents an analysis of the In Silico ADME/Tox market landscape. Although, the market is at an embryonic stage of development, the insurgence in the number of companies and products offered to this market clearly reflects significant opportunity.
Furthermore, in this report qualitative and quantitative market analysis of In Silico ADME/Tox products is presented. Also presented is the potential market opportunity, and the various factors that are driving and/or restraining the growth of this market.
Key Highlights of this report:
Overview of the drug discovery process
Regulatory requirements for drug approval
The importance of ADME/Tox screening in drug discovery
Market Drivers and Restraints
Industry Challenges
In Silico ADME/Tox screening product analysis
Quantitative market research
Competitive Factors
Published: June 2006, Pages: 180
Table of Contents
Table of Contents
Price
Single User Print Version $2,500.00
Electronic Site License (pdf + one print copy) $3,000.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.